Rocklatan, the brand name for netarsudil ophthalmic solution, is a medication prescribed for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension [1].
What is Rocklatan's mechanism of action?
Rocklatan works by inhibiting both rho-kinase (ROCK) and to a lesser extent, norepinephrine transporter (NET) [1]. Inhibition of ROCK leads to relaxation of the trabecular meshwork, increasing aqueous humor outflow through the uveoscleral pathway. Inhibition of NET enhances the reuptake of norepinephrine, which can also contribute to increased aqueous humor outflow [1].
How is Rocklatan administered?
Rocklatan is administered as a single drop in the affected eye(s) once daily [1].
What are the key components of Rocklatan prescribing information?
Key aspects of Rocklatan prescribing information include its indication for lowering IOP, its dual mechanism of action involving rho-kinase and norepinephrine transporter inhibition, and its recommended dosage and administration [1]. It also details contraindications, warnings, precautions, adverse reactions, and drug interactions [1].
What are the common side effects associated with Rocklatan?
The most common adverse reaction reported in clinical trials was conjunctival hyperemia, occurring in approximately 50% of patients. Other frequently reported side effects include [1]:
* Corneal verticillata (approximately 30%)
* Eye pain (approximately 15%)
* Instillation site reaction (approximately 10%)
* Hyphema (approximately 10%)
When should Rocklatan not be used?
Rocklatan is contraindicated in patients with known hypersensitivity to its active ingredient or any of its inactive ingredients [1].
What are the potential risks or precautions when using Rocklatan?
Patients using Rocklatan may experience conjunctival hyperemia and subconjunctival hemorrhage. Caution should be exercised in patients with a history of keratitis, corneal effacement, or corneal endothelial disease. There is also a potential for additive effect on IOP reduction with other topical ocular hypotensive agents [1].
How does Rocklatan compare to other glaucoma medications?
Rocklatan's unique dual mechanism of action, inhibiting both ROCK and NET, distinguishes it from other glaucoma medications that primarily focus on reducing aqueous humor production or increasing outflow through other pathways. This dual action allows for a comprehensive approach to lowering intraocular pressure [1].
When does Rocklatan's patent exclusivity expire?
Information on the specific patent expiry dates for Rocklatan is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [2].